Resistance Mechanisms in Hepatitis C Virus: implications for Direct-Acting Antiviral Use.
Drugs • Vol. 77, Issue 10 • 2017
New combination antiviral for the treatment of hepatitis C.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists • Vol. 73, Issue 14 • 2016
Update on Current Evidence for Hepatitis C Therapeutic Options in HCV Mono-infected Patients.
Current infectious disease reports • Vol. 18, Issue 7 • 2016
Ombitasvir/paritaprevir/ritonavir and dasabuvir tablets for hepatitis C virus genotype 1 infection.
The Annals of pharmacotherapy • Vol. 49, Issue 5 • 2015
